<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03606811</url>
  </required_header>
  <id_info>
    <org_study_id>IORG0003301</org_study_id>
    <nct_id>NCT03606811</nct_id>
  </id_info>
  <brief_title>Fluoroscopic &amp;Ultrasonographic Guidance of Superior Hypogastric Plexus Neurolysis in Intractable Pelvic Pain</brief_title>
  <official_title>The Role of Double Modality &quot; Fluoroscopic &amp;Ultrasonographic &quot; Guidance of Superior Hypogastric Plexus Neurolysis in Treating Intractable Pelvic Cancer Pain: a Comparative Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      fluoroscopic group &amp; includes 30 patients where SHPB will be done Fluoroscopic-guided (the
      posterior oblique trajectory technique.the double modality group &amp; includes 30 patients where
      SHPB will be done using our described new technique of performing the modified Mishra
      technique by injecting 3-5 ml of contrast media (lohexol=omnipaque) after getting the target
      position.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 5, 2018</start_date>
  <completion_date type="Actual">August 15, 2019</completion_date>
  <primary_completion_date type="Actual">August 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain relief will be assessed by VAS</measure>
    <time_frame>12 weeks</time_frame>
    <description>pain relief will be assessed by VAS (visual Analogue score) which is 100 mscale with left (0) end means no pain &amp; right (10) end means the worst possible pain</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Intractable Pelvic Cancer Pain</condition>
  <arm_group>
    <arm_group_label>fluroscopic guided block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>double modality guided block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>fluroscopic guided block</intervention_name>
    <description>SHPB will be done Fluoroscopic-guided (the posterior oblique trajectory technique.</description>
    <arm_group_label>fluroscopic guided block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>double modality (ultrasound and fluroscopic) guided block</intervention_name>
    <description>SHPB will be done using our described new technique of performing the modified Mishra technique by injecting 3-5 ml of contrast media (lohexol=omnipaque) after getting the target position. Then C-arm pictures will be checked (both P-A &amp; dead lateral)</description>
    <arm_group_label>double modality guided block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years.

          -  Intractable pelvic cancer pain (VAS &gt; 40 mm)

          -  Pain is refractory to pharmacotherapy (both opioids and adjuvant therapy) or opioids'
             side effects are not tolerated.

        Exclusion criteria

          -  Local or systemic sepsis.

          -  Uncorrectable coagulopathy.

          -  Neuropsychiatric illness.

          -  History of drug abuse.

          -  Pregnant or lactating patients.

          -  Distorted local anatomy.

          -  Patients who are known to be allergic to the used medications.

          -  Cardiovascular or respiratory instability.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>NCI, Cairo university</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>July 14, 2018</study_first_submitted>
  <study_first_submitted_qc>July 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2018</study_first_posted>
  <last_update_submitted>January 11, 2020</last_update_submitted>
  <last_update_submitted_qc>January 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed H Othman</investigator_full_name>
    <investigator_title>Assisstant professor of Anesthesia ICU and pain Relief</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pelvic Neoplasms</mesh_term>
    <mesh_term>Cancer Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

